Insider Transactions in Q1 2025 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Kevin Charles Gorman Director |
SELL
Open market or private sale
|
Direct |
146,105
-22.11%
|
$21,769,645
$149.46 P/Share
|
|
Jan 27
2025
|
Kevin Charles Gorman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
146,105
+18.11%
|
$4,675,360
$32.99 P/Share
|
|
Jan 15
2025
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,000
-17.1%
|
$9,165,000
$141.5 P/Share
|
|
Jan 15
2025
|
Kyle Gano Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+13.43%
|
$2,080,000
$32.99 P/Share
|